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Background: Vitreo-retinal diseases are among the leading causes of visual impairment and blindness worldwide.
This study reports the prevalence and pattern of vitreo-retinal diseases in the Bhaktapur Glaucoma Study (BGS), a
population based study conducted in Nepal.
Methods: BGS was a population based cross-sectional study involving 4800 subjects aged 40 years and over from
Bhaktapur district. Subjects were selected using a cluster sampling methodology and a door-to-door enumeration.
All subjects underwent a detailed ocular examination at the base hospital which included log MAR visual acuity,
refraction, applanation tonometry and a dilated fundus examination. Fundus photography, optical coherence
tomography and fundus fluorescein angiography were performed where indicated.
Results: Complete data was available for 3966 (82.62%) out of the total of 4800 enumerated subjects. The mean
age was 55.08 years (SD 11.51). The overall prevalence of vitreo-retinal disorders was 5.35% (95% CI, 4.67 - 6.09).
Increasing age was associated with a higher prevalence of vitreo-retinal disorders (P < 0.001). The prevalence of
diabetes mellitus was 7.69% (95% CI, 6.88 - 8.56). Age-related macular degeneration (AMD) was the most common
vitreo-retinal disorder with a prevalence of 1.50% (95% CI, 1.15 - 1.94), increasing significantly with age. The
prevalence of diabetic retinopathy among the study population was 0.78% (95% CI, 0.53 - 1.11) and among the
diabetic population 10.16% (95% CI, 7.01 - 14.12). The population prevalence of other retinal disorders were
hypertensive retinopathy 0.88%, macular scar 0.37%, retinal vein occlusion 0.50%, macular hole 0.20%, retinitis
pigmentosa 0.12%. and retinal detachment 0.10%.
The prevalence of low vision and blindness due to vitreo-retinal disorders was 1.53% (95% CI, 1.18 - 1.97) and 0.65%
(95% CI, 0.43 - 0.96), respectively. The prevalence of low vision and blindness was 28.77% (95% CI, 22.78-35.37) and
12.26% (95% CI, 8.17-17.45), respectively among cases with vitreo-retinal disorders. Blindness was observed to be
unilateral in 19 cases (73%), and bilateral in 7 cases (27%).
Conclusions: The prevalence of vitreo-retinal disorders in this Nepalese population was 5.35%, which increased
significantly with age. AMD was the predominant retinal condition followed by diabetic retinopathy. One fourth of
the subjects with vitreo-retinal disorder had low vision. Taking into consideration the aging population and
emerging systemic diseases such as diabetes mellitus and hypertension, vitreo-retinal disorders could be of future
public health importance.
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Vitreo-retinal diseases as a group are one of the more
common ocular morbidities leading to blindness in the
adult population, while being the most common cause
of blindness worldwide in children [1]. Population based
studies reported an overall prevalence of vitreo-retinal
disorders of 8.56%, with a range between 10.4% and
21.02% for the 40 years and over age group [2,3]. Age
related macular degeneration (AMD) is the third com-
monest cause of blindness globally and is the leading
cause of irreversible blindness among the elderly in de-
veloped countries, contributing to 8.7% of total blindness
[4-7]. Likewise, diabetic retinopathy (DR) is the fifth
leading cause of visual impairment and blindness glo-
bally, and is the most common cause of new cases of
blindness among working aged adults in the developed
world [4,8-10]. In the developing world, which harbours
almost 90% of the world’s blind population, retinal dis-
eases are among the leading cause of blindness after
cataract [11]. In Asia, vitreo-retinal diseases are becom-
ing an increasing problem, with expectations that more
than half of the world’s diabetic patients will live in
Asian countries by the year 2030 [12-17].
The Nepal Blindness Survey of 1981 reported retinal
disorders to be the third leading cause of bilateral blind-
ness after cataract and its sequelae [18]. After the 1981
survey there have been several population based studies
in Nepal that have reported the prevalence of blindness
from retinal diseases within a range of 1% to 10.8%
[19,20]. Based on these studies, it has been reported that
AMD and retinal detachment are the major causes of
visual impairment.
A recent population based study conducted in the
Bhaktapur district reported that vitreo-retinal diseases
were the second major cause of blindness following cata-
ract, while being the most common cause of blindness
among pseudophakics [21,22]. This paper will further
elaborate the findings from this population based study
regarding the prevalence, types and visual impairment
from vitreo-retinal disorders in this district. While previ-
ous studies have only reported on the overall prevalence
of blindness from eye disorders including retinal dis-
eases, this will be the first study to report the prevalence
and pattern of vitreo-retinal disease in Nepal.
Methods
The methods and demographics of the study population
have been published in detail elsewhere [23]. In brief;
the survey involved the selection of 4800 subjects aged
40 years or older residing in the Bhaktapur district.
Bhaktapur is situated approximately 15 kilometres away
from the capital city of Kathmandu. It is located within
the mid-mountain region of Nepal. A sample size of
4758 was calculated after assuming a prevalence of 3 %for glaucoma based on studies in the region, a relative
precision of 25%, 85% compliance and a design effect of
2. A total of 4800 subjects were enumerated. A 2-stage
World Health Organization 30-cluster sampling proced-
ure was adopted for patient selection [24]. The sampling
frame comprised 161 wards and an estimated population
of 48,223 people aged over 40 years [25]. In the first
stage, 30 wards were selected and field workers conducted
a census. In the second stage, a database was prepared
and names of all eligible subjects were recorded, and then
subjects were selected randomly. From this list, 4800 sub-
jects were selected using EPI-INFO software, version 3.5.1
(Centers for Disease Control and Prevention, Atlanta,
GA). Selected subjects were revisited by field workers and
referred to Tilganga Institute of Ophthalmology for a
comprehensive eye examination. The study was approved
by the institutional review board of Tilganga Institute of
Ophthalmology and conducted in accordance with the
Declaration of Helsinki. Informed consent was obtained
from all subjects after explaining all the procedures to be
undertaken. The informed consent was written in the ver-
nacular. For those unable to read, the consent form was
read out to them. Upon agreement by the subject, they
were asked to sign the consent form. For those unable to
sign, thumb impressions were taken. Bhaktapur district
was chosen because it did not have an eye hospital and for
logistic reasons in order to conduct a large population
based study.Clinical examination
Two ophthalmologists were involved in the clinical
examination of all the subjects as per the protocol [23].
Patients with vitreo-retinal disorders were referred to a
fellowship trained vitreo-retina specialist for confirm-
ation of diagnosis and further management. All referred
patients were examined by the vitreo -retinal (VR) spe-
cialist on the same day. This was possible as the study
was conducted patients at a tertiary eye hospital where
the glaucoma and retina units work on the same days of
the week.
The visual acuity (VA) was measured using logarithm
of minimum angle of resolution (logMAR) with tumbling
E charts placed at 4 metres. Slit-lamp biomicroscopy (BQ
900, Haag-streit International, Koeniz, Switzerland) was
performed to identify ocular abnormalities. Fundus evalu-
ation was performed with the aid of 90 D and 20 D lens
(Volk optical Inc, Mentor, OH0). All subjects had their
pupils dilated. Those with risk of angle closure underwent
peripheral iridectomy before pupil dilatation. The lens was
examined and cataract graded according to lens opacities
Classification System 2 (LOCS II) [26]. Fundus examin-
ation included evaluation of the optic disc, macula, ves-
sels, and central and peripheral retina.
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fication developed by the International ARM Epidemio-
logical Study Group [27]. Briefly, drusen were defined as
discrete whitish-yellow spots external to the neuroretinal
pigment epithelium or retinal pigment epithelium (RPE).
The largest drusen determined the grade for maximum
drusen size and predominant drusen type. Type was
based on the size of drusen, uniformity of appearance
across the breadth, and the sharpness of edges. Pigmentary
abnormalities included either increased pigmentation asso-
ciated with drusen or depigmentation or hypopigmentation
of the RPE, more sharply demarcated than drusen, without
any visibility of choroidal vessels associated with drusen.
Geographic atrophy was defined as any sharply delineated,
approximately round or oval area of hypopigmentation or
depigmentation, or apparent absence of the RPE in which
choroidal vessels are more visible than in surrounding
areas, at least 175 μm. Wet AMD was defined as the pres-
ence of any of the following: (1) RPE detachments or serous
detachment of the sensory retina, (2) sub retinal or sub-
RPE neovascular membranes, (3) subretinal haemorrhages
and (4) epiretinal, subretinal, intraretinal, or sub pigment
epithelial scar or glial tissue or fibrin like deposits.
The assessment of diabetes mellitus was based on ei-
ther the use of diabetic medications or a random blood
sugar level of 200 mg/dl or greater. Glycosylated haemo-
globin was not measured.
DR was categorized as per the Early Treatment Dia-
betic Retinopathy Study [28]. Briefly, DR was classified
into various stages of non proliferative (NPDR) and pro-
liferative DR. Clinically significant macular oedema was
defined as retinal oedema located at or within 500 μm of
the centre of the macula or hard exudates at or within
500 μm of the centre, if associated with thickening of
adjacent retina, or a zone of thickening larger than 1
disc area if located within 1 disc diameter of the centre
of the macula.
We defined systemic hypertension as either a mea-
sured systolic blood pressure of 140 mmHg or greater,
or a diastolic blood pressure of 90 mmHg or greater, or
current use of systemic antihypertensive medications.
Fluorescein angiography, Optical Coherence Tomog-
raphy (OCT) and surgical interventions were carried out
based upon the expert opinion of the VR surgeon. FFA
and OCT were also done as a baseline to evaluate the
treatment outcome.
The International Classification of Diseases 10th edi-
tion defines visual impairment as VA less than 6/18 (20/
60, 0.3) in the better eye with best correction [29]. Visual
impairment has been categorized into blindness and low
vision. A VA of less than 3/60 (20/400, 0.05) with best
correction in the better eye has been considered blind-
ness. Low vision has been defined as a best-corrected
VA of less than 6/18 (20/60, 0.3) but not less than 3/60(20/400, 0.05) in the better eye. VA was based on the eye
with vitreo-retinal disease in unilateral cases and on the
better eye in bilateral cases. The prevalence of disease
was based upon the number of subjects and not eyes. So
if subjects had glaucoma in one eye and a retinal path-
ology in the other, they were counted separately.
Statistical analysis
Descriptive measures such as mean, standard deviation
for continuous variables, ratios and percentages for cat-
egorical variables were computed. The prevalence esti-
mates with 95% confidence intervals were calculated
using binomial distribution. Univariate and multivariate
logistic regression analysis was carried out to see the as-
sociation between the probable risk factors with vitreo-
retinal diseases. Statistical analysis was performed using
STATA 9.0 (Stata Corporation, College Station, Texas,
U.S.A.).
Results
Complete data was available for 3966 (82.62%) out of
the total of 4800 subjects. The mean age was 55.08 years
(SD 11.51), with a range from 40 years to 96 years.
Males comprised of 45.51% and females 54.49% of the
total study group. The total number of non-responders
was 834 (46% males and 54% females). The mean age of
non-responders was 54.72 years (SD 10.92) which was
not statistically significant in comparison to the re-
sponders.The overall prevalence of various vitreo-retinal
disorders was 5.35% (95% CI, 4.67 - 6.09). Increasing age
was associated with a higher prevalence of vitreo-retinal
disorders (P < 0.001), as shown in Table 1. The preva-
lence was 1.96% (95% CI, 1.32 – 2.80) for the age group
40–49 years, compared to 28.57% (95% CI, 3.67 - 70.90)
for the age group 90 years and above. There was no sig-
nificant difference in the age-adjusted prevalence of
vitreo-retinal disorders between sexes.
Table 2 shows the pattern of various vitreo-retinal dis-
orders seen in this population. AMD (28.3%) was the
most common vitreo-retinal disorder. The prevalence of
AMD was 1.5% (95% CI, 1.15-1.94); 1.38% (95% CI,
0.89-2.04) was noted in males and 1.62% (95% CI, 1.13-
2.24) in females. The mean age of subjects with AMD
was 69.28 years (SD 12.31). Table 3 shows the prevalence
of AMD in different age groups. There was a significant
association between AMD and increasing age. Sex was
not a risk factor for AMD.
DR comprised of 17.9% of the vitreo-retinal disorders,
which was second to AMD. The prevalence of diabetes
mellitus was 7.69% (95% CI, 6.88 - 8.56) in the study
population, out of which known and newly diagnosed di-
abetics comprised of 6% (95% CI, 5.28 - 6.79) and 1.69%
(95% CI, 1.31 - 2.14), respectively. The overall prevalence
of DR was 0.78% (95% CI, 0.53 - 1.11) among the study
Table 1 Age and sex distribution of vitreo-retinal diseases in the study population
Characteristics No. of participants Prevalence% V-R disorders (95% CI) Crude OR (95% CI) Adjusted OR (95% CI)
Age
40 - 49 1477 1.96 (1.32, 2.80) 1.00 1.00
50 - 59 1080 4.54 (3.37, 5.95) 2.37 (1.49, 3.78) 2.38 (1.49, 3.79)
60 - 69 837 7.05 (5.41, 8.99) 3.79 (2.40, 5.96) 3.81 (2.42, 5.99)
70 - 79 475 12.42 (9.59, 15.73) 7.08 (4.48, 11.19) 7.10 (4.49, 11.22)
80 - 89 90 15.60 (8.77, 24.72) 9.19 (4.67, 18.12) 9.20 (4.67, 18.14)
≥90 7 28.57 (3.67, 70.9) 19.97 (3.72, 107.22) 20.24 (3.76, 108.78)
Sex
Male 1805 5.20 (4.23, 6.34 ) 1.00 1.00
Female 2161 5.46 (4.54, 6.50) 1.05 (0.79, 1.39) 1.09 (0.82, 1.45)
Total 3966 5.35 (4.67, 6.09) - -
No, number; CI, confidence interval; OR, odds ratio; V-R, vitreo-retinal.
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diabetic population. The prevalence of diabetes and DR
among the general and diabetic population is shown in
Table 3. The prevalence of diabetes was higher with in-
creasing age. The prevalence of NPDR was 0.93% (95%
CI, 0.65 - 1.28) in our study population. There were only
two cases with clinically significant macular oedema and
one case with proliferative DR (Table 2,3).Table 2 Pattern of vitreo-retinal disorders in Bhaktapur





















No: number, ARMD: age-related macular degeneration, ERM: epiretinal membrane,
vitreous detachment.The other common vitreo-retinal disorders were
hypertensive retinopathy (16.5%), branch retinal vein oc-
clusion (8.96%), macular scar (7.07%) and retinal detach-
ment (1.89%) among the vitreo-retinal disorders.
The prevalence of various grades of hypertensive retin-
opathy was 0.88%, retinal vein occlusion 0.5%, and
branch retinal vein occlusion 0.47%. There was only one
case with central retinal vein occlusion. The prevalencePersons. No. (%) Eyes. No. (%)
60 (28.30) 113 (31.56)
15 (7.07) 17 (4.74)
8 (3.77) 10 (2.79)
2 (0.94) 2 (0.55)
1 (0.47) 2 (0.55)
38 (17.90) 76 (21.20)
35 (16.50) 70 (19.50)
19 (8.96) 19 (5.30)
5 (2.36) 10 (2.79)
4 (1.89) 4 (1.10)
4 (1.89) 4 (1.10)
2 (0.94) 2 (0.55)
1 (0.47) 1 (0.27)
1 (0.47) 1 (0.27)
1 (0.47) 2 (0.55)
1 (0.47) 1 (0.27)
9 (4.24) 11 (3.07)
1 (0.47) 8 (2.23)
5 (2.35) 5 (1.39)
212 358
HTN: hypertension, BRVO: branch retinal vein occlusion, PVD: posterior
Table 3 Prevalence of age-related macular degeneration, diabetes and diabetic retinopathy
Age group Prevalence(% ) with CI
of AMD among study
population
Prevalence(% ) with CI
of diabetes mellitus among
study population
Prevalence(% ) with CI of
diabetic retinopathy among
study population
Prevalence(% ) with CI of
diabetic retinopathy among
diabetic subjects
40-49 0.27 (0.073-0.69) 4.74 (3.71-5.95) 0.61 (0.28 - 1.15) 12.86 (6.05 - 23.00)
50-59 0.56 (0.20-1.20) 7.96 (6.42-9.74) 0.83 (0.38 - 1.58) 10.46 (4.89 - 18.94)
60-69 1.90 (1.09-3.08) 10.63 ( 8.63-12.92) 1.79 (1.00 - 2.94) 16.85 (9.75 - 26.27)
70-79 5.05 (3.26-7.42) 10.74 (8.09-13.87) 0.84 (0.23 - 2.14) 7.84 (2.18 - 18.88)
80-89 8.89 (3.92-16.76) 7.78 (3.58-15.37) 1.11 (0.03 - 6.04) 14.28 (0.36 - 57.87)
≥90 28.57 (3.67-70.96) 28.57 (3.67-70.95) No cases
(Diabetic retinopathy n= 38; total diabetic subjects n= 305).
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macular scar 0.37%, macular hole 0.2%, retinitis pig-
mentosa 0.12% and retinal detachment 0.1%. Posterior
vitreous detachment was found in 0.22% of cases
(Table 2).
Table 4 shows the VA distribution among the subjects
with vitreo-retinal disorders. Low vision was found in
28.8% (95% CI, 22.78 - 35.37), while 12.26% (95% CI,
8.17 - 17.45) of cases were blind. The blindness was uni-
lateral in 19 cases (73%) and bilateral in 7 cases (27%).
Prevalence of low vision and blindness due to vitreo-Table 4 Visual acuity distribution among cases with vitreo-re
Characteristics Number of cases with vitreo-retinal disea
Age (years)
40 - 49 29
50 - 59 49
60 - 69 59
70 - 79 59
















Note: Visual acuity was based on the eye with vitreo-retinal diseases in unilateral c
best-corrected visual acuity of <6/18 (20/60, 0.3) but not <3/60 (20/400, 0.05).retinal disorders was 1.54% (95% CI, 1.18 - 1.97) and
0.65% (95% CI, 0.43 - 0.96) respectively. Both low vision
and blindness were more prevalent in the older age
groups. The prevalence of blindness was higher among
females than males. Among those with AMD, 40% had
low vision and 8.33% were blind. Low vision and blind-
ness among the cases with DR was 10.5% and 2.6% re-
spectively. Likewise, 42.10% of cases had low vision and
15.78% were blind among the cases with branch retinal
vein occlusion. The rate of blindness was high (75%)
among cases of retinal detachment.tinal disorders
ses Normal vision No. (%) Low vision No. (%) Blind No. (%)
24 (82.75) 4 (13.79) 1(3.40)
31 (63.26) 9 (18.36) 9 (18.36)
39 (66.10) 16 (27.10) 4 (6.80)
27 (45.76) 25 (42.37) 7 (11.86)
4 (28.57) 5 (35.71) 5 (35.71)
0 (0.00) 2 (100.00) 0 (0.00)
62 (65.90) 23 (24.40) 9 (9.50)
63 (53.38) 38 (32.20) 17 (14.40)
31 (51.67) 24 (40%) 5 (8.33)
33 (86.80) 4 (10.50) 1 (2.60)
30 (85.70) 5 (14.30) 0
8 (42.10) 8 (42.10) 3 (15.78)
5 (33.33) 5 (33.33) 5 (33.33)
3 (37.50) 4 (50) 1 (12.5)
0 4 (80) 1 (20)
0 1 (25) 3 (75)
15 (53.57) 6 (21.40) 7 (25)
125 (59) 61 (28.80) 26 (12.20)
ases and on the better eye in bilateral cases. Low vision has been defined as a
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This is the first population based study to report the
prevalence of vitreo-retinal disorders in Nepal. Our find-
ings are not representative of Nepal because of the di-
verse ethnic races seen in the country that could play a
role in the etiology of various eye diseases. However
considering the similarity in socioeconomic conditions,
geographic terrain and the ethnic races with the
neighbouring two districts, our findings could be repre-
sentative of Kathmandu valley. The findings of this study
will be useful for gauging the pattern of vitreo-retinal
disorders in the Bhaktapur district, and thus assist with
guiding future public health interventions for the area. It
also importantly has the potential to be extrapolated to
the two neighbouring districts of Kathmandu and
Lalitpur, due to similar demographics and geography.
The overall prevalence of vitreo-retinal disorders in this
study was 5.35%, a figure which is lower than some of
the reports from around the region [2,3]. There lies the
possibility in our study for an underestimation of the
overall prevalence of vitreo-retinal disorders, due to the
fact the original design was primarily for the study of
glaucoma. In addition, the inability to perform fundus
photography on all subjects may have also lead to an
underestimation. Despite these factors, the prevalence of
vitreo- retinal disorders was higher than the overall
prevalence of glaucoma (1.2%). In investigating the
prevalence of vitreo-retinal disorders and its association
with age and gender, we found there to be a significant
increase in prevalence with age (P<0.001), while there
was no significant difference with gender in our study.
These findings are consistent with those previously
reported in the literature [2,3].
AMD has been the most common vitreo-retinal dis-
ease found in previous studies [2,3]. As in developed na-
tions of the world, the increased prevalence of AMD in
developing countries such as Nepal is likely to be due to
an ever increasing ageing population and improving
health facilities [30]. Other factors potentially related
could be exposure to smoking, as well as unprotected
exposure to ultraviolet radiation. This latter is a pertin-
ent issue in Nepal where the majority of the population
work in fields without adequate protective eye wears
[31-33]. The prevalence of AMD in our study (1.5%) was
similar to the findings of a previous study (1.8%)
conducted among those over 40 years in the Indian State
of Andhra Pradesh [34], but lower than other studies
such as the Aravind comprehensive eye study (2.5% in
the over 40 years age group) and the India Eye study
(3.8% in the over 50 years age group) [3,35]. A study
from China by Wu et al. showed a prevalence of 10.6%
among those over 50 years [36]. Similarly studies from
other developed countries have showed the prevalence
of AMD to range from 8-20% [37-39]. The higherprevalence in those countries could be due to racial vari-
ations, as well as the longevity of life of people in those
regions. The prevalence of AMD in our study was higher
with increasing age, a finding consistent with the above
mentioned studies. These findings emphasise that with
longevity, AMD could become a significant public health
problem in Nepal. As with other population based stud-
ies [2,3], we did not find statistically significant differ-
ences in the prevalence of AMD with gender.
The prevalence of diabetes mellitus in our study
(7.69%) was comparable to that previously published
in the literature [40,41]. Demonstrating a range in
published data, one previous population based study
conducted in a semi-urban community of Nepal, found
a lower prevalence of 4.1% [42], while other studies from
the region have presented a higher prevalence [41,43].
This disparity in the prevalence of diabetes could be due
to the fact that our study population is predominantly
involved in agriculture, where a relatively high level of
physical activity may play a role in the lower incidence
of diabetes. DR (prevalence of 10.16%) among our dia-
betic population, as well as in our overall study pop-
ulation (0.78%) was higher than those found in India,
the study of Nirmalan et al. [3], but lower than other
population based studies ranging from 18% to 63%
[10,40-43]. Reasons for our lower prevalence could in-
clude a better glycemic control in this population due to
better access to health care services. The higher preva-
lence of diabetes with increasing age was consistent with
the series from India [3]. We found a higher prevalence
of DR among the age group 40–49 years in our series
despite a comparably lower prevalence of diabetes. This
observed finding alerts to the importance of regular and
timely ocular examinations in the relatively younger
population.
The prevalence of hypertensive retinopathy (0.88%) in
a significant proportion of our population was in keep-
ing with the findings of previous population based stud-
ies, reflecting that hypertension is a major public health
concern in Nepal [44,45]. Retinal vein occlusion on the
contrary had a prevalence of 0.5% which was lower than
figures from a recent Japanese study (2.1%) [46] and
some other studies conducted in the western world
[47,48] but similar to findings from a study in Asia [49]
Macular hole, another sight threatening retinopathy, was
found in our study population to have a prevalence of
0.2%, compared to a lower prevalence in the Beijing eye
study (0.09%) [50], the Aravind comprehensive eye study
[3], and a study by Sen et al. (0.16%) [51]. This may have
been contributed by ocular trauma, especially in the
younger age groups. The prevalence of retinitis pigment-
osa, was not different from the study conducted by Sen
et al. [52] but lower than that reported in the Aravind
comprehensive eye study [3]. The high number of retinal
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creased awareness, education and prompt ocular assess-
ment because of its severe visual consequences with
delayed treatment. Factors that may affect rates of retinal
detachment include improper management of intra-
operative complications following cataract surgery and
complications related to significant ocular trauma. Simi-
larly, rates of macular scar in our population would be a
result of trauma and sequelae of intraocular inflammation.
Almost two-fifths of eyes with vitreo-retinal disorders
suffered from visual impairment, while blindness was
present in 12.2% of eyes. The blindness was bilateral in
one quarter of cases. The higher prevalence of visual
impairment (1.54%) and blindness (0.65%) due to vitreo-
retinal disorders among those over 40 years of age
emphasises the need for routine eye examinations begin-
ning at this age group and also promoting awareness of
eye diseases. AMD, sequelae of retinal vein occlusion,
retinal detachment and macular scar were the major
causes of blindness in our study. The rate of visual im-
pairment and blindness from vitreo-retinal disorders in
our study was consistent with findings from previous
studies conducted in Nepal [18-22]. A higher rate of
blindness among females in our study could probably be
due to the fact that males had better access to health
care services than females.
Conclusions
The prevalence of vitreo-retinal disorder in our popula-
tion was 5.35%. AMD, DR, hypertensive retinopathy and
retinal vein occlusion were the major retinal problems.
The prevalence of vitreo-retinal disorders increased with
age and reflects that retinal disorders will be a major
public health concern with longevity in Nepal. Promot-
ing awareness in the population in regard to regular eye
examination and also addressing risk factors that could
lead to vitreo retinal disorders will play a significant role
in reducing blindness from this group of eye diseases.
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